Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Operating Expenses | 2,037 | 1,729 | 2,472 | 2,873 | 22,359 |
| Operating Income | -2,037 | -1,729 | -2,472 | -2,873 | -22,359 |
| Interest Expense | 0 | 0 | 0 | 0 | 1,528 |
| Other Income | 868 | 188 | 20 | -141 | 1,147 |
| Pre-tax Income | -1,169 | -1,541 | -2,452 | -3,014 | -22,740 |
| Income Tax | 12 | 3 | 3 | 14 | -1,473 |
| Net Income Continuous | -1,181 | -1,544 | -2,455 | -3,028 | -21,267 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 3,935 |
| Net Income | $-1,181 | $-1,544 | $-2,455 | $-3,028 | $-17,332 |
| EPS Basic Total Ops | -0.08 | -0.11 | -0.18 | -0.23 | -1.30 |
| EPS Basic Continuous Ops | -0.08 | -0.11 | -0.18 | -0.23 | -1.59 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.29 |
| EPS Diluted Total Ops | -0.08 | -0.11 | -0.18 | -0.23 | -1.30 |
| EPS Diluted Continuous Ops | -0.08 | -0.11 | -0.18 | -0.23 | -1.59 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.29 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.11 | -0.18 | -0.23 | -1.59 |
| EBITDA(a) | $-2,037 | $-1,729 | $-2,472 | $-2,873 | $-20,423 |